ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABVX, PTGX, ROIV, IMVT, TERN, and represent 28.33% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: DNLI (+$35M), BEAM (+$35M), TERN (+$30M), CRNX (+$30M), VIR (+$25M), DBVT (+$21M), INSP (+$20M), SRRK (+$17M), SYRE (+$15M), AVR (+$14M).
- Started 74 new stock positions in PSNL, DMRA, TRDA, MGNX, DNTH, MPLT, SRZN, Bridgebio Pharma, FOLD, TOI.
- Reduced shares in these 10 stocks: Avidity Biosciences Ord (-$39M), RAPT (-$17M), CDTX (-$13M), Aa Mission Acquisition Corp (-$11M), ABUS (-$10M), CBIO (-$10M), FULC (-$9.1M), BBIO (-$8.8M), TFX (-$7.1M), CLDX (-$6.9M).
- Sold out of its positions in GRCE, AstraZeneca, Astria Therapeutics, AUPH, Avidity Biosciences Ord, BBOT, Ceridian Hcm Hldg, CDTX, ZONE, DVAX.
- ADAR1 Capital Management was a net buyer of stock by $323M.
- ADAR1 Capital Management has $1.7B in assets under management (AUM), dropping by 24.76%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 300 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 9.4 | $160M | +9% | 1.4M | 111.35 |
|
| Protagonist Therapeutics (PTGX) | 6.2 | $105M | -5% | 994k | 105.40 |
|
| Roivant Sciences SHS (ROIV) | 5.4 | $91M | -4% | 3.3M | 27.70 |
|
| Immunovant (IMVT) | 3.9 | $67M | +7% | 2.7M | 24.84 |
|
| Terns Pharmaceuticals Call Option (TERN) | 3.5 | $59M | +105% | 1.1M | 52.72 |
|
| State Str Spdr S&p 500 Etf T Tr Unit (SPY) | 2.9 | $49M | +38% | 76k | 650.34 |
|
| Cytokinetics Com New (CYTK) | 2.5 | $42M | +17% | 633k | 65.91 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $41M | +268% | 1.1M | 36.32 |
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 2.3 | $39M | 337k | 116.29 |
|
|
| Denali Therapeutics (DNLI) | 2.1 | $36M | +3490% | 1.9M | 19.20 |
|
| Beam Therapeutics (BEAM) | 2.0 | $35M | NEW | 1.4M | 23.83 |
|
| Zai Lab Adr (ZLAB) | 1.6 | $27M | +14% | 1.4M | 18.81 |
|
| Septerna (SEPN) | 1.5 | $26M | -5% | 1.1M | 24.03 |
|
| Vir Biotechnology (VIR) | 1.4 | $25M | NEW | 2.7M | 8.96 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 1.2 | $21M | NEW | 1.0M | 20.89 |
|
| Anteris Technologies Global (AVR) | 1.2 | $21M | +205% | 3.8M | 5.55 |
|
| Inspire Med Sys (INSP) | 1.2 | $21M | +2601% | 405k | 51.58 |
|
| Scholar Rock Hldg Corp (SRRK) | 1.2 | $20M | +485% | 407k | 49.16 |
|
| Rhythm Pharmaceuticals (RYTM) | 1.1 | $18M | +311% | 212k | 86.97 |
|
| Spyre Therapeutics Com New (SYRE) | 1.0 | $17M | +893% | 338k | 50.44 |
|
| Cytomx Therapeutics (CTMX) | 0.9 | $16M | -20% | 3.4M | 4.70 |
|
| Prothena Corp SHS (PRTA) | 0.9 | $15M | +8% | 1.6M | 9.72 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.9 | $15M | +399% | 317k | 48.18 |
|
| Vaxcyte (PCVX) | 0.9 | $15M | -17% | 259k | 58.11 |
|
| Monopar Therapeutics Com New (MNPR) | 0.9 | $15M | +12% | 264k | 54.79 |
|
| Arbutus Biopharma (ABUS) | 0.8 | $14M | -42% | 3.1M | 4.50 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.8 | $14M | +12% | 1.0M | 13.90 |
|
| Celldex Therapeutics Com New (CLDX) | 0.8 | $14M | -33% | 428k | 31.72 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $13M | +19% | 3.0M | 4.47 |
|
| Xenon Pharmaceuticals (XENE) | 0.8 | $13M | +12% | 229k | 58.15 |
|
| Sutro Biopharma Com Shs (STRO) | 0.8 | $13M | +681% | 524k | 24.91 |
|
| Revolution Medicines (RVMD) | 0.8 | $13M | -7% | 134k | 97.25 |
|
| Enliven Therapeutics (ELVN) | 0.8 | $13M | +998% | 330k | 39.20 |
|
| Replimune Group Call Option (REPL) | 0.8 | $13M | +32% | 1.7M | 7.65 |
|
| Cg Oncology (CGON) | 0.7 | $13M | -28% | 186k | 67.68 |
|
| Spdr Series Trust State Street Spd (BIL) | 0.7 | $12M | 136k | 91.64 |
|
|
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $12M | +24% | 214k | 56.78 |
|
| Inventiva Sa Ads (IVA) | 0.7 | $12M | -19% | 2.2M | 5.55 |
|
| Ionis Pharmaceuticals (IONS) | 0.7 | $12M | +8% | 160k | 75.09 |
|
| Nektar Therapeutics Com New (NKTR) | 0.7 | $12M | +123% | 161k | 71.95 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $11M | -18% | 6.6M | 1.68 |
|
| Silverback Therapeutics (SPRY) | 0.6 | $11M | +268% | 1.4M | 8.03 |
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs | 0.6 | $10M | NEW | 1.0M | 10.30 |
|
| Ovid Therapeutics (OVID) | 0.6 | $10M | +6% | 4.5M | 2.22 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.6 | $10M | +140% | 2.4M | 4.14 |
|
| Regeneron Pharmaceuticals (REGN) | 0.6 | $9.4M | 12k | 772.64 |
|
|
| Moonlake Immunotherapeutics Class A Ord Call Option (MLTX) | 0.5 | $8.9M | NEW | 477k | 18.64 |
|
| Lexeo Therapeutics (LXEO) | 0.5 | $8.4M | +5% | 1.5M | 5.74 |
|
| Ocuphire Pharma (IRD) | 0.5 | $8.4M | +4522% | 1.8M | 4.55 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.5 | $8.1M | +13% | 268k | 30.12 |
|
| Savara (SVRA) | 0.5 | $8.0M | +4% | 1.5M | 5.46 |
|
| Maplight Therapeutics (MPLT) | 0.4 | $7.6M | NEW | 375k | 20.33 |
|
| Athira Pharma (LONA) | 0.4 | $7.5M | +84% | 728k | 10.28 |
|
| Equillium (EQ) | 0.4 | $7.5M | -33% | 3.7M | 2.00 |
|
| Viking Therapeutics (VKTX) | 0.4 | $7.4M | +759% | 228k | 32.54 |
|
| Damora Therapeutics Com New (DMRA) | 0.4 | $7.2M | NEW | 279k | 25.90 |
|
| Urogen Pharma (URGN) | 0.4 | $7.1M | +139% | 396k | 17.98 |
|
| Bridgebio Pharma (BBIO) | 0.4 | $7.0M | -55% | 94k | 74.26 |
|
| Prime Medicine (PRME) | 0.4 | $6.9M | NEW | 2.0M | 3.48 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.4 | $6.8M | -30% | 28k | 248.00 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.4 | $6.7M | +9% | 15k | 446.54 |
|
| Korro Bio (KRRO) | 0.4 | $6.1M | NEW | 540k | 11.32 |
|
| Miragen Therapeutics (VRDN) | 0.4 | $6.0M | +294% | 304k | 19.56 |
|
| Danaher Corporation (DHR) | 0.3 | $5.9M | +20% | 31k | 189.60 |
|
| Insmed Com Par $.01 (INSM) | 0.3 | $5.8M | NEW | 35k | 163.52 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $5.7M | 25k | 228.73 |
|
|
| Brighthouse Finl (BHF) | 0.3 | $5.7M | 96k | 59.88 |
|
|
| Sarepta Therapeutics (SRPT) | 0.3 | $5.7M | +807% | 262k | 21.76 |
|
| Oaktree Acquisition Corp Iii Unit 10/04/2029 (OACCU) | 0.3 | $5.5M | 517k | 10.65 |
|
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.3 | $5.5M | +9% | 500k | 10.97 |
|
| Krystal Biotech (KRYS) | 0.3 | $5.2M | 20k | 258.32 |
|
|
| Acumen Pharmaceuticals (ABOS) | 0.3 | $5.1M | +141% | 2.2M | 2.36 |
|
| Adagio Therapeutics (IVVD) | 0.3 | $5.0M | 3.8M | 1.30 |
|
|
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.3 | $4.9M | NEW | 45k | 109.84 |
|
| Bhav Acquisition Corp Unit 03/18/2031 | 0.3 | $4.9M | NEW | 495k | 9.97 |
|
| Protara Therapeutics Com Stk (TARA) | 0.3 | $4.9M | -17% | 941k | 5.21 |
|
| Bridgebio Pharma Note 1.750% 3/0 (Principal) | 0.3 | $4.9M | NEW | 30k | 161.73 |
|
| Agios Pharmaceuticals (AGIO) | 0.3 | $4.8M | -25% | 141k | 33.83 |
|
| Eli Lilly & Co. (LLY) | 0.3 | $4.7M | NEW | 5.1k | 919.77 |
|
| Dianthus Therapeutics (DNTH) | 0.3 | $4.6M | NEW | 55k | 83.92 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $4.4M | +20% | 70k | 62.70 |
|
| Belite Bio Sponsored Ads (BLTE) | 0.3 | $4.3M | -32% | 27k | 159.44 |
|
| Evommune Com Shs (EVMN) | 0.2 | $4.2M | 184k | 22.99 |
|
|
| Mineralys Therapeutics (MLYS) | 0.2 | $4.2M | +13% | 155k | 27.09 |
|
| Janux Therapeutics (JANX) | 0.2 | $4.1M | +21% | 299k | 13.90 |
|
| Eliem Therapeutics (CLYM) | 0.2 | $4.1M | -58% | 598k | 6.85 |
|
| Palisade Bio (PALI) | 0.2 | $4.0M | +12% | 2.3M | 1.75 |
|
| American Exceptionalism Acqu Ord Cl A (AEXA) | 0.2 | $3.9M | 358k | 10.83 |
|
|
| Spruce Biosciences Com New (SPRB) | 0.2 | $3.8M | 59k | 65.35 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $3.8M | 119k | 32.01 |
|
|
| Liquidia Corporation Com New Put Option (LQDA) | 0.2 | $3.8M | +308% | 100k | 37.74 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.2 | $3.8M | +12% | 630k | 5.95 |
|
| Arcellx Common Stock (ACLX) | 0.2 | $3.7M | 32k | 114.82 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 0.2 | $3.6M | 277k | 13.06 |
|
|
| Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $3.6M | NEW | 20k | 178.20 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $3.5M | 216k | 16.45 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 0.2 | $3.5M | NEW | 12k | 296.97 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $3.4M | +27% | 367k | 9.39 |
|
| Tenax Therapeutics Com New (TENX) | 0.2 | $3.4M | +235% | 214k | 15.99 |
|
| Arrivent Biopharma (AVBP) | 0.2 | $3.3M | NEW | 142k | 23.07 |
|
| Pliant Therapeutics (PLRX) | 0.2 | $3.3M | +3401% | 2.6M | 1.26 |
|
| Ataibeckley Com Shs (ATAI) | 0.2 | $3.2M | NEW | 913k | 3.54 |
|
| Relmada Therapeutics (RLMD) | 0.2 | $3.1M | +1364% | 452k | 6.96 |
|
| Perspective Therapeutics Com New (CATX) | 0.2 | $3.1M | +687% | 749k | 4.17 |
|
| Eledon Pharmaceuticals (ELDN) | 0.2 | $3.0M | -46% | 974k | 3.08 |
|
| Pharvaris N V (PHVS) | 0.2 | $3.0M | +23% | 106k | 28.25 |
|
| Apellis Pharmaceuticals (APLS) | 0.2 | $2.9M | +262% | 73k | 40.23 |
|
| Uniqure Nv SHS Call Option (QURE) | 0.2 | $2.9M | -33% | 176k | 16.35 |
|
| Edgewise Therapeutics (EWTX) | 0.2 | $2.9M | 91k | 31.50 |
|
|
| Pepgen (PEPG) | 0.2 | $2.8M | +4263% | 1.6M | 1.77 |
|
| Capricor Therapeutics Com New (CAPR) | 0.2 | $2.8M | NEW | 91k | 30.40 |
|
| Masimo Corporation (MASI) | 0.2 | $2.7M | 15k | 177.87 |
|
|
| Inovio Pharmaceuticals Com Shs (INO) | 0.2 | $2.6M | -5% | 1.5M | 1.74 |
|
| Teleflex Incorporated (TFX) | 0.1 | $2.5M | -73% | 21k | 119.61 |
|
| Bright Minds Biosciences Com New (DRUG) | 0.1 | $2.5M | +868% | 34k | 72.97 |
|
| Bioage Labs (BIOA) | 0.1 | $2.4M | 136k | 17.49 |
|
|
| Alector (ALEC) | 0.1 | $2.3M | -5% | 1.1M | 2.15 |
|
| Pfizer (PFE) | 0.1 | $2.2M | +6% | 77k | 28.08 |
|
| Delcath Sys Com New (DCTH) | 0.1 | $2.1M | 224k | 9.28 |
|
|
| Biogen Idec (BIIB) | 0.1 | $2.0M | -54% | 11k | 183.33 |
|
| Connect Biopharma Hldgs SHS (CNTB) | 0.1 | $1.9M | NEW | 742k | 2.62 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 0.1 | $1.9M | NEW | 15k | 127.73 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $1.9M | +583% | 342k | 5.57 |
|
| Summit Therapeutics (SMMT) | 0.1 | $1.7M | 92k | 18.96 |
|
|
| Globus Med Cl A (GMED) | 0.1 | $1.7M | 20k | 86.16 |
|
|
| Novo-nordisk A S Adr (NVO) | 0.1 | $1.7M | NEW | 46k | 36.75 |
|
| Alkermes SHS (ALKS) | 0.1 | $1.6M | -27% | 46k | 35.36 |
|
| Soleno Therapeutics (SLNO) | 0.1 | $1.6M | +11% | 47k | 33.48 |
|
| Cohen Circle Acquisit Corp I Unit 07/01/2030 (CCIIU) | 0.1 | $1.6M | 150k | 10.34 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.1 | $1.5M | -9% | 433k | 3.58 |
|
| Supernus Pharmaceuticals (SUPN) | 0.1 | $1.5M | 30k | 51.69 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $1.5M | 39k | 39.72 |
|
|
| Amicus Therapeutics (FOLD) | 0.1 | $1.5M | NEW | 105k | 14.46 |
|
| Maze Therapeatics (MAZE) | 0.1 | $1.5M | -72% | 50k | 29.85 |
|
| UnitedHealth (UNH) | 0.1 | $1.5M | NEW | 5.5k | 270.59 |
|
| Adagio Med Hldgs (ADGM) | 0.1 | $1.4M | +3% | 1.2M | 1.15 |
|
| Forward Air Corp (FWRD) | 0.1 | $1.3M | +193% | 78k | 16.71 |
|
| Sensient Technologies Corporation (SXT) | 0.1 | $1.3M | NEW | 15k | 86.44 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.1 | $1.3M | -6% | 27k | 48.15 |
|
| Corvus Pharmaceuticals (CRVS) | 0.1 | $1.3M | -81% | 88k | 14.63 |
|
| Satellos Bioscience | 0.1 | $1.3M | NEW | 223k | 5.63 |
|
| Promis Neurosciences Com Shs (PMN) | 0.1 | $1.2M | NEW | 95k | 12.70 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $1.2M | NEW | 750k | 1.56 |
|
| Schrodinger (SDGR) | 0.1 | $1.2M | NEW | 102k | 11.36 |
|
| Xencor (XNCR) | 0.1 | $1.1M | +66% | 94k | 12.06 |
|
| Omniab (OABI) | 0.1 | $1.1M | 705k | 1.57 |
|
|
| 4d Molecular Therapeutics In (FDMT) | 0.1 | $1.1M | 117k | 9.31 |
|
|
| Keros Therapeutics (KROS) | 0.1 | $1.1M | +416% | 97k | 11.04 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $1.1M | NEW | 50k | 21.44 |
|
| Bristol Myers Squibb (BMY) | 0.1 | $1.1M | -12% | 18k | 60.65 |
|
| Tango Therapeutics (TNGX) | 0.1 | $1.0M | -64% | 50k | 20.92 |
|
| Tenaya Therapeutics (TNYA) | 0.1 | $1.0M | 1.5M | 0.69 |
|
|
| Best Spac I Acquisition Corp Unit 05/27/2030 (BSAAU) | 0.1 | $1.0M | 100k | 10.40 |
|
|
| McKesson Corporation (MCK) | 0.1 | $1.0M | 1.2k | 865.36 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.1 | $1.0M | +41% | 18k | 56.49 |
|
| Arrowhead Pharmaceuticals In Note 1/1 | 0.1 | $1.0M | NEW | 10k | 102.40 |
|
| Oruka Therapeutics (ORKA) | 0.1 | $1.0M | 21k | 49.05 |
|
|
| Electronic Arts (EA) | 0.1 | $1.0M | 4.9k | 203.87 |
|
|
| Fulcrum Therapeutics (FULC) | 0.1 | $1.0M | -90% | 131k | 7.67 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1000k | +133% | 105k | 9.52 |
|
| Guardant Health (GH) | 0.1 | $924k | +42% | 10k | 92.37 |
|
| Crescent Biopharma (CBIO) | 0.1 | $924k | -91% | 50k | 18.37 |
|
| Context Therapeutics (CNTX) | 0.1 | $920k | 351k | 2.62 |
|
|
| Engene Holdings (ENGN) | 0.1 | $910k | -55% | 134k | 6.81 |
|
| Silence Therapeutics Ads (SLN) | 0.1 | $907k | +628% | 172k | 5.27 |
|
| Alexandria Real Estate Equities (ARE) | 0.1 | $905k | +19% | 20k | 46.42 |
|
| Keen Vision Acquisition Corp SHS Call Option (KVAC) | 0.1 | $900k | 75k | 12.00 |
|
|
| Ibio Com New (IBIO) | 0.1 | $893k | +15% | 470k | 1.90 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $889k | 10k | 88.88 |
|
|
| Gilead Sciences (GILD) | 0.1 | $885k | -4% | 6.4k | 139.37 |
|
| Nurix Therapeutics (NRIX) | 0.1 | $869k | -22% | 56k | 15.50 |
|
| Dyne Therapeutics (DYN) | 0.1 | $861k | -9% | 48k | 18.13 |
|
| Intuitive Surgical Com New (ISRG) | 0.0 | $844k | +79% | 1.8k | 460.99 |
|
| Adlai Nortye Sponsored Ads (ANL) | 0.0 | $816k | NEW | 118k | 6.92 |
|
| Ww Intl Com New (WW) | 0.0 | $793k | 58k | 13.74 |
|
|
| Atrium Therapeutics (RNA) | 0.0 | $771k | NEW | 58k | 13.37 |
|
| Integer Hldgs (ITGR) | 0.0 | $770k | NEW | 8.8k | 88.00 |
|
| Compass Therapeutics (CMPX) | 0.0 | $735k | 139k | 5.29 |
|
|
| Nuvalent Inc-a (NUVL) | 0.0 | $711k | 6.9k | 102.45 |
|
|
| Cullinan Oncology (CGEM) | 0.0 | $711k | 50k | 14.21 |
|
|
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.0 | $700k | +234% | 33k | 20.95 |
|
| Ideaya Biosciences (IDYA) | 0.0 | $666k | 20k | 33.32 |
|
|
| Fractyl Health Call Option (GUTS) | 0.0 | $654k | 1.4M | 0.46 |
|
|
| Enanta Pharmaceuticals (ENTA) | 0.0 | $649k | +24% | 51k | 12.63 |
|
| Vera Therapeutics Cl A (VERA) | 0.0 | $645k | +8% | 16k | 40.23 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $636k | +319% | 1.1M | 0.60 |
|
| Boston Scientific Corporation (BSX) | 0.0 | $628k | +100% | 10k | 62.75 |
|
| Avantor (AVTR) | 0.0 | $627k | +14% | 80k | 7.84 |
|
| Arvinas Ord (ARVN) | 0.0 | $611k | 58k | 10.60 |
|
|
| Kezar Life Sciences Com New (KZR) | 0.0 | $608k | -30% | 82k | 7.42 |
|
| Kalaris Therapeutics (KLRS) | 0.0 | $577k | 100k | 5.77 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $573k | NEW | 6.2k | 92.38 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.0 | $567k | -62% | 3.0k | 189.05 |
|
| Assembly Biosciences Com New (ASMB) | 0.0 | $554k | 20k | 27.75 |
|
|
| Prelude Therapeutics (PRLD) | 0.0 | $523k | NEW | 153k | 3.42 |
|
| Globa Terra Acquisition Cor Unit 99/99/9999 (GTERU) | 0.0 | $518k | 50k | 10.36 |
|
|
| Wisdomtree Tr Floatng Rat Trea (USFR) | 0.0 | $503k | 10k | 50.34 |
|
|
| Aclaris Therapeutics (ACRS) | 0.0 | $497k | -78% | 132k | 3.75 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.0 | $483k | 1.5k | 322.19 |
|
|
| Pulmonx Corp (LUNG) | 0.0 | $483k | +5% | 375k | 1.29 |
|
| Elanco Animal Health (ELAN) | 0.0 | $479k | 20k | 23.93 |
|
|
| Phathom Pharmaceuticals (PHAT) | 0.0 | $477k | 43k | 11.11 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $469k | 895.00 | 523.47 |
|
|
| Polypid (PYPD) | 0.0 | $455k | 104k | 4.38 |
|
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.0 | $449k | 3.6k | 125.46 |
|
|
| Core Scientific (CORZ) | 0.0 | $449k | 30k | 14.96 |
|
|
| Aadi Bioscience (WHWK) | 0.0 | $443k | +65% | 129k | 3.45 |
|
| Natera (NTRA) | 0.0 | $429k | 2.1k | 199.99 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $429k | 751k | 0.57 |
|
|
| Therapeuticsmd Com New (TXMD) | 0.0 | $423k | 209k | 2.02 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $409k | +45% | 18k | 23.36 |
|
| Tectonic Therapeutic (TECX) | 0.0 | $402k | -56% | 13k | 30.91 |
|
| Entrada Therapeutics (TRDA) | 0.0 | $385k | NEW | 31k | 12.62 |
|
| Biohaven (BHVN) | 0.0 | $379k | +30% | 45k | 8.46 |
|
| Merck & Co (MRK) | 0.0 | $378k | -67% | 3.1k | 120.29 |
|
| Verastem Com New (VSTM) | 0.0 | $377k | NEW | 71k | 5.30 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $372k | -69% | 44k | 8.38 |
|
| Adicet Bio Com New (ACET) | 0.0 | $367k | -58% | 54k | 6.81 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.0 | $362k | NEW | 20k | 18.09 |
|
| Surrozen Com New (SRZN) | 0.0 | $350k | NEW | 12k | 29.13 |
|
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $338k | +80% | 145k | 2.34 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $331k | NEW | 71k | 4.64 |
|
| Neurocrine Biosciences (NBIX) | 0.0 | $329k | NEW | 2.5k | 131.74 |
|
| Wave Life Sciences SHS (WVE) | 0.0 | $326k | NEW | 45k | 7.25 |
|
| Kura Oncology (KURA) | 0.0 | $325k | 40k | 8.13 |
|
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $324k | 168k | 1.93 |
|
|
| Corcept Therapeutics Incorporated (CORT) | 0.0 | $323k | NEW | 8.0k | 40.31 |
|
| Upstream Bio (UPB) | 0.0 | $315k | NEW | 35k | 9.00 |
|
| Orthopediatrics Corp. (KIDS) | 0.0 | $315k | 20k | 15.87 |
|
|
| Annexon (ANNX) | 0.0 | $305k | +14% | 55k | 5.54 |
|
| Geron Corporation (GERN) | 0.0 | $298k | -40% | 200k | 1.49 |
|
| Jd.com Spon Ads Cl A (JD) | 0.0 | $296k | 10k | 29.57 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $286k | +128% | 231k | 1.24 |
|
| Traws Pharma Com New (TRAW) | 0.0 | $282k | 154k | 1.83 |
|
|
| Jade Biosciences Com New (JBIO) | 0.0 | $281k | -4% | 20k | 14.05 |
|
| Procap Acquisition Corp Unit 05/16/2030 (PCAPU) | 0.0 | $279k | 27k | 10.34 |
|
|
| Bicara Therapeutics (BCAX) | 0.0 | $273k | 14k | 19.89 |
|
|
| Rxsight (RXST) | 0.0 | $266k | +98% | 43k | 6.16 |
|
| Palo Alto Networks (PANW) | 0.0 | $257k | NEW | 1.6k | 160.32 |
|
| Intellia Therapeutics (NTLA) | 0.0 | $250k | NEW | 20k | 12.82 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 0.0 | $250k | NEW | 640.00 | 390.41 |
|
| Rubrik Cl A (RBRK) | 0.0 | $240k | NEW | 4.9k | 48.97 |
|
| Royalty Pharma Shs Class A (RPRX) | 0.0 | $240k | NEW | 5.0k | 47.97 |
|
| Surgery Partners (SGRY) | 0.0 | $238k | 20k | 11.92 |
|
|
| Larimar Therapeutics (LRMR) | 0.0 | $237k | -71% | 53k | 4.50 |
|
| Evolus (EOLS) | 0.0 | $230k | +55% | 56k | 4.11 |
|
| Q32 Bio (QTTB) | 0.0 | $225k | +75% | 35k | 6.42 |
|
| Longeveron Cl A New (LGVN) | 0.0 | $208k | NEW | 200k | 1.04 |
|
| Anaptysbio Inc Common (ANAB) | 0.0 | $205k | NEW | 3.7k | 55.46 |
|
| Cantor Equity Partners Vi In Cl A Ord Shs (CEPS) | 0.0 | $202k | NEW | 20k | 10.10 |
|
| Kalvista Pharmaceuticals (KALV) | 0.0 | $201k | 10k | 20.13 |
|
|
| Kyverna Therapeutics (KYTX) | 0.0 | $194k | -60% | 22k | 8.63 |
|
| Nuvation Bio Com Cl A (NUVB) | 0.0 | $187k | NEW | 44k | 4.29 |
|
| Benitec Biopharma Com New (BNTC) | 0.0 | $186k | NEW | 18k | 10.65 |
|
| Lipocine Com New (LPCN) | 0.0 | $185k | NEW | 23k | 7.99 |
|
| Rallybio Corp (RLYB) | 0.0 | $184k | NEW | 21k | 8.97 |
|
| Rezolute Com New (RZLT) | 0.0 | $179k | +51% | 59k | 3.05 |
|
| Q/c Technologies (QCLS) | 0.0 | $173k | NEW | 50k | 3.45 |
|
| Erasca (ERAS) | 0.0 | $162k | NEW | 10k | 16.18 |
|
| Coya Therapeutics Common Stock (COYA) | 0.0 | $161k | NEW | 41k | 3.94 |
|
| Personalis Ord (PSNL) | 0.0 | $159k | NEW | 25k | 6.37 |
|
| Si-bone (SIBN) | 0.0 | $159k | NEW | 13k | 12.63 |
|
| Oncology Institu (TOI) | 0.0 | $154k | NEW | 50k | 3.07 |
|
| Cybin Com New (HELP) | 0.0 | $150k | -86% | 31k | 4.80 |
|
| Neuronetics (STIM) | 0.0 | $145k | NEW | 100k | 1.45 |
|
| Ardelyx (ARDX) | 0.0 | $143k | NEW | 24k | 5.99 |
|
| Inflarx Nv (IFRX) | 0.0 | $142k | NEW | 158k | 0.89 |
|
| Achieve Life Sciences (ACHV) | 0.0 | $141k | 48k | 2.94 |
|
|
| Voyager Therapeutics (VYGR) | 0.0 | $135k | 35k | 3.86 |
|
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $126k | 80k | 1.57 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $123k | 140k | 0.88 |
|
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $122k | 30k | 4.07 |
|
|
| Milestone Pharmaceuticals (MIST) | 0.0 | $119k | 100k | 1.19 |
|
|
| Arcturus Therapeutics Hldg I (ARCT) | 0.0 | $116k | NEW | 15k | 7.72 |
|
| Macrogenics (MGNX) | 0.0 | $116k | NEW | 40k | 2.89 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $113k | NEW | 43k | 2.63 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $108k | 35k | 3.07 |
|
|
| Design Therapeutics (DSGN) | 0.0 | $106k | NEW | 10k | 10.64 |
|
| Gossamer Bio (GOSS) | 0.0 | $95k | -59% | 288k | 0.33 |
|
| Immix Biopharma (IMMX) | 0.0 | $91k | -80% | 10k | 9.11 |
|
| Solidion Technology Com New Call Option (STI) | 0.0 | $85k | 14k | 6.31 |
|
|
| Mei Pharma (LITS) | 0.0 | $78k | 67k | 1.16 |
|
|
| Veru Com New (VERU) | 0.0 | $77k | 35k | 2.21 |
|
|
| Kyntra Bio Com New (KYNB) | 0.0 | $71k | 11k | 6.78 |
|
|
| Clover Health Investments Com Cl A (CLOV) | 0.0 | $70k | -17% | 40k | 1.76 |
|
| Biomea Fusion (BMEA) | 0.0 | $66k | 43k | 1.53 |
|
|
| Neumora Therapeutics (NMRA) | 0.0 | $65k | -34% | 33k | 1.95 |
|
| Organon & Co Common Stock (OGN) | 0.0 | $60k | -71% | 10k | 5.99 |
|
| Esperion Therapeutics (ESPR) | 0.0 | $59k | NEW | 21k | 2.74 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.0 | $50k | 150k | 0.33 |
|
|
| An2 Therapeutics (ANTX) | 0.0 | $47k | NEW | 14k | 3.42 |
|
| A Spac Iii Acquisition Corp Right 01/02/2026 (ASPCR) | 0.0 | $42k | 215k | 0.20 |
|
|
| Aquestive Therapeutics (AQST) | 0.0 | $42k | -96% | 10k | 4.15 |
|
| Atyr Pharma Com New (ATYR) | 0.0 | $40k | 51k | 0.78 |
|
|
| Bioatla (BCAB) | 0.0 | $37k | +24% | 228k | 0.16 |
|
| Kala Bio Com New (KALA) | 0.0 | $25k | 142k | 0.17 |
|
|
| Coherus Biosciences (CHRS) | 0.0 | $18k | 10k | 1.69 |
|
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.0 | $16k | 10k | 1.62 |
|
|
| Cortexyme Put Option (QNCX) | 0.0 | $10k | -18% | 100k | 0.10 |
|
| Immunic (IMUX) | 0.0 | $0 | NEW | 30k | 0.00 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2026 Q1 filed May 18, 2026
- ADAR1 Capital Management 2025 Q4 restated filed Feb. 18, 2026
- ADAR1 Capital Management 2025 Q4 filed Feb. 17, 2026
- ADAR1 Capital Management 2025 Q3 filed Nov. 14, 2025
- ADAR1 Capital Management 2025 Q2 filed Aug. 14, 2025
- ADAR1 Capital Management 2025 Q1 filed May 15, 2025
- ADAR1 Capital Management 2024 Q4 filed Feb. 13, 2025
- ADAR1 Capital Management 2024 Q3 filed Nov. 14, 2024
- ADAR1 Capital Management 2024 Q2 filed Aug. 13, 2024
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024